SCHEDULE 13G/A: Janus Henderson Group PLC Discloses 9.9% Stake in ICU Medical, Inc.
Beneficial Ownership Disclosure
Janus Henderson Group PLC and its affiliate, Janus Henderson Enterprise Fund, have disclosed significant beneficial ownership stakes in ICU Medical, Inc. through a Schedule 13G filing.
Summary
- Janus Henderson Group PLC, a Jersey-based parent holding company and investment adviser, reported beneficial ownership of 2,410,782 shares of ICU Medical, Inc. Common Stock, representing 9.9% of the class.
- Janus Henderson Enterprise Fund, a Massachusetts-based investment company, reported beneficial ownership of 1,230,753 shares of ICU Medical, Inc. Common Stock, representing 5.0% of the class.
- Both entities hold shared voting and shared dispositive power over their respective reported shares.
- The filing is an Amendment No. 9 to a Schedule 13G, indicating a passive investment intent, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing (Schedule 13G) disclosing beneficial ownership, which is inherently neutral in sentiment. It does not contain positive or negative operational information about the issuer.
Future Outlook
This Schedule 13G filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding ICU Medical, Inc.'s future performance or operations.
Industry Context
This filing reflects a passive investment by a major asset manager in a medical technology company. Such disclosures are routine for large institutional investors crossing specific ownership thresholds and typically do not indicate a change in the issuer's operational strategy or market position, but rather an investment decision by the reporting entity.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake by Janus Henderson Group PLC and Janus Henderson Enterprise Fund may be viewed positively by some shareholders as it indicates institutional confidence in ICU Medical, Inc. However, as a passive investment, it does not imply active engagement or strategic changes.
Key Dates
| Date | Description |
|---|---|
| 2022-12-09 | Date of execution for the Power of Attorney appointing Kristin Mariani and Caroline Barotti as attorneys-in-fact. |
| 2024-12-31 | Date of event which requires the filing of this statement. |
| 2025-02-14 | Signature date of the Schedule 13G filing by Kristin Mariani on behalf of Janus Henderson Group PLC and Janus Henderson Enterprise Fund. |
Keywords
Janus Henderson Group PLC, ICU Medical Inc., Schedule 13G, Beneficial Ownership, Investment Management, Common Stock, SEC Filing, Institutional Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.